Wuyi, China

Linggang Tao

This inventor holds 11 USPTO granted patents and 4 published patent applications. Top assignees: Hainan Lingkang Pharmaceutical Co., Ltd, Tianjin University. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linggang Tao. Retrieved from https://idiyas.com/inventor/linggang-tao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 9.1

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Wuyi, CN (2014 - 2015)
  • Wuyi County, CN (2014 - 2015)
  • Haikou, CN (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Linggang Tao: A Pioneer in Pharmaceutical Innovations**

Introduction

Linggang Tao, an accomplished inventor based in Wuyi, China, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 11 patents. His innovative work is focused on developing advanced compounds and preparation methods that enhance the effectiveness of medications.

Latest Patents

Among Linggang Tao's latest patents is the invention titled "Omeprazole Sodium Semihydrate and Preparation Method Thereof." This patent details a formulation where every mole of Omeprazole Sodium semihydrate contains 0.5 mole of water. The invention is notable for its unique X-ray diffraction pattern, featuring characteristic peaks at specific diffraction angles. The method involves adding a raw material of Omeprazole Sodium hydrate into an organic solvent and stirring it at a controlled temperature, ultimately yielding the semihydrate after filtration and drying.

Another significant patent by Tao is related to the "Crystalline Form of Cefamandole Nafate Compound, Preparation and Preparing Method Thereof." This invention defines a novel crystalline form of Cefamandole Nafate characterized by specific diffraction angles identified through X-ray powder diffraction and differential scanning calorimetry (DSC). The method employs stirring a suspension of Cefamandole Nafate in an organic solvent, followed by controlled cooling and suction filtration to produce the desired crystalline form.

Career Highlights

Linggang Tao's career is highlighted by his role in several prominent organizations, including Hainan Lingkang Pharmaceutical Co., Ltd and Tianjin University. His work has not only contributed to the field of pharmaceutical sciences but has also positioned him as an influential figure within the industry.

Collaborations

Throughout his career, Linggang Tao has collaborated with notable professionals, including colleagues Hongxun Hao and Baohong Hou. These collaborations have fostered an environment of innovation and have led to the successful development of various pharmaceutical inventions.

Conclusion

In summary, Linggang Tao stands out as a significant inventor in the field of pharmaceuticals, recognized for his innovative approaches to drug formulation and preparation methodologies. His contributions, marked by a solid patent portfolio, continue to influence advancements in the pharmaceutical industry, making him a valuable asset to his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…